PATENT CLAIM ANALYSIS

Application Number: 16312063
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "248000"]

Abstract:
Provided are certain compounds or pharmaceutically acceptable salts thereof which can inhibit kinase activity of Bruton's tyrosine kinase (BTK) and may be useful for the treatment of diseases like cancer, immunological disease and inflammation.

Claim (Index 6):
A compound of  claim 1  or a pharmaceutically acceptable salt thereof, wherein L is selected from \u2014O\u2014 and \u2014C(O)NH\u2014.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15763095', '12598912', '14418484', '13859569', '15676852']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8261805016593055
- 35 USC 102 Novelty (BERT): 0.544409398801744
- Combined Prediction Score: 0.7980033913735494
- Mean Citation Score: 406.030806
- Max Citation Score: 412.5569
- Similarity Product: 271.1783944108069

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test